What should the Lantus (glargine) dose be for a patient with insulin-dependent diabetes, currently receiving 4 units/hour of insulin via drip and D5 (dextrose 5%) at 100ml/hr, once the D5 is stopped?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Transitioning from Insulin Drip to Lantus: Calculating the Basal Dose

Immediate Calculation and Administration

For a patient requiring 4 units/hour of IV insulin, start with 48 units of Lantus once daily, calculated as 50% of the total 24-hour IV insulin requirement (4 units/hour × 24 hours = 96 units; 50% = 48 units), and administer this dose 1-2 hours BEFORE discontinuing the insulin drip to prevent rebound hyperglycemia. 1

Critical Timing Protocol

  • The first dose of Lantus must be given 1-2 hours before stopping the IV insulin drip to ensure adequate overlap, as IV insulin has a very short plasma half-life and discontinuation without prior subcutaneous coverage will cause rapid metabolic decompensation 1
  • Never discontinue IV insulin without prior subcutaneous dosing, especially in insulin-dependent patients, as this precipitates dangerous hyperglycemia 1

Accounting for Nutritional Status

The D5 infusion at 100 mL/hr provides continuous carbohydrate load (approximately 120 grams/24 hours) that requires BOTH basal AND nutritional insulin coverage—the 48 units of Lantus addresses only the basal component. 1

When D5 Continues After Transition

  • If D5 continues running, add nutritional insulin coverage using either regular insulin every 6 hours OR rapid-acting insulin every 4 hours, calculated at approximately 1 unit per 10-15 grams of carbohydrate in the dextrose solution 1
  • The basal insulin dose (48 units Lantus) remains unchanged regardless of nutritional status, but additional scheduled nutritional insulin is required for ongoing dextrose infusion 1

When D5 is Stopped

  • If D5 is discontinued and the patient is NPO (nothing by mouth), the 48 units of Lantus provides adequate basal coverage alone 1
  • However, if the patient begins eating after D5 is stopped, prandial insulin must be added—start with 4 units of rapid-acting insulin before the largest meal or 10% of the basal dose 2

Risk-Based Dose Adjustments

Reduce the calculated 48-unit dose by 20-50% in high-risk populations to prevent severe hypoglycemia. 1

High-Risk Patient Categories

  • Elderly patients (>65 years): Use 0.1-0.25 units/kg/day instead of standard dosing 2, 1
  • Patients with renal impairment: For CKD Stage 5, reduce total daily insulin by 50% for type 2 diabetes or 35-40% for type 1 diabetes 2, 1
  • Patients with poor oral intake: Reduce dose by 20-50% and monitor glucose every 4-6 hours 1

Post-Transition Monitoring and Titration

Immediate Monitoring Requirements

  • Check point-of-care glucose every 4-6 hours initially after transition, with more frequent monitoring if the patient was previously unstable on the drip 1
  • Daily fasting blood glucose monitoring is essential during the titration phase 2

Evidence-Based Titration Algorithm

  • Increase Lantus by 2 units every 3 days if fasting glucose is 140-179 mg/dL 2, 1
  • Increase Lantus by 4 units every 3 days if fasting glucose is ≥180 mg/dL 2, 1
  • Target fasting plasma glucose: 80-130 mg/dL 2
  • If hypoglycemia occurs without clear cause, reduce dose by 10-20% immediately 2

Critical Threshold: Recognizing When Basal Insulin Alone Is Insufficient

When the Lantus dose exceeds 0.5 units/kg/day (approximately 35-40 units for a 70 kg patient) and glucose remains elevated, this signals the need for prandial insulin coverage rather than further basal insulin escalation. 2, 1

Signs of Overbasalization

  • Basal insulin dose >0.5 units/kg/day 2
  • Bedtime-to-morning glucose differential ≥50 mg/dL 2
  • Episodes of hypoglycemia with persistent hyperglycemia at other times 2
  • High glucose variability throughout the day 2

Common Pitfalls to Avoid

  • Never use sliding scale insulin alone during the transition—this approach treats hyperglycemia reactively rather than preventing it, leading to dangerous glucose fluctuations 1
  • Do not forget nutritional insulin coverage if the patient continues receiving dextrose or begins eating, as continuous carbohydrate load requires scheduled insulin beyond basal coverage 1
  • Do not continue escalating basal insulin beyond 0.5-1.0 units/kg/day without addressing postprandial hyperglycemia, as this leads to overbasalization with increased hypoglycemia risk 2, 1

References

Guideline

Estimating Lantus Dose from Insulin Drip Requirements

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

Is it safe to take Lantus (insulin glargine) twice a day?
What should be the Lantus (insulin glargine) dose, carbohydrate ratio, and correction scale for a 62-year-old female with a body mass index (BMI) of 28, weighing 68 kg, on Lantus 8 units at home and Novolog (insulin aspart) 12 units three times a day, who received dexamethasone (DEX) 8 mg and has poor oral intake?
Can a patient with morning hypoglycemia take Lantus (insulin glargine) 14 units at night and 16 units during the day?
What is the recommended insulin management for a patient with diabetes taking Lantus (insulin glargine) 20 units and a sliding scale, undergoing an esophagogastroduodenoscopy (EGD) and colonoscopy?
Is it better to administer 54 units of Lantus (insulin glargine) once daily or twice daily?
What is the appropriate evaluation and management for a patient presenting with an intermittent split S2 (second heart sound)?
What are the causes of microalbuminuria, particularly in patients with diabetes (Diabetes Mellitus) and hypertension?
How do you determine if a patient with Acute Myeloid Leukemia (AML) is at intermediate, favorable, or adverse risk?
What does a positive sphincterotomy indicate in an adult patient with a history of gallstones, biliary duct obstruction, or recurrent pancreatitis?
What is the best surgical approach for a 64-year-old female with diabetes mellitus (DM) and hypertension (HTN), who has a history of lumbar spine fusion from L2 to L5, and now presents with adjacent segment disease at L1/2 with severe central and foraminal stenosis, bilateral thigh dysesthesia and pain, and a diseased L5/S1 disc with vacuum phenomenon, considering her recent improvement in blood sugar control from an elevated Hemoglobin A1c (HbA1c) of 8.9?
What is the recommended duration of Dual Antiplatelet Therapy (DAPT) for a patient with a 2.5 mm x 22 mm stent in the proximal to mid Left Anterior Descending (LAD) artery?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.